Regulatory Affairs

AI Document Editor for Regulatory Affairs Teams

Regulatory affairs teams produce the most consequential documents in their organization — submissions that determine market access, technical files that survive auditor scrutiny, and compliance records that prove adherence. Vespper is built for this kind of writing.

1. EU MDR Compliance Landscape

Regulatory affairs teams must navigate the full scope of EU MDR requirements across the product lifecycle.

EU MDR 2017/745

  • Classification rules (Annex VIII) determining documentation tier requirements
  • Annex I General Safety and Performance Requirements mapping
  • Annex II technical documentation requirements and Annex III post-market surveillance documentation
  • EUDAMED registration and UDI-DI assignment obligations
Impact on documentation
  • Higher-risk classification triggers more extensive documentation requirements that RA teams must manage
  • EUDAMED submission deadlines require coordinated documentation readiness across multiple deliverables

2. FDA Regulatory Pathways

US market access requires pathway-specific documentation that RA teams must prepare and maintain.

FDA Submission and QSR

  • 510(k) premarket notification process and substantial equivalence demonstration
  • De Novo classification and PMA requirements for novel devices
  • Quality System Regulation (21 CFR Part 820) documentation requirements
  • Unique Device Identification (UDI) system requirements and GUDID registration
Impact on documentation
  • Each FDA pathway has distinct documentation requirements that cannot be interchanged
  • QSR documentation must be maintained continuously — not just prepared at submission time

3. International Market Access

Global regulatory strategies require documentation tailored to each market's requirements.

Multi-Jurisdiction Requirements

  • Health Canada Medical Device Regulations and licensing requirements
  • MDSAP audit program covering 5 jurisdictions with single audit approach
  • Japan PMDA Shonin and Todokede pathways with Japan-specific clinical requirements
  • Australia TGA registration and conformity assessment procedures
Impact on documentation
  • MDSAP findings affect all participating jurisdictions simultaneously
  • Each market may require country-specific clinical data beyond global dossier content

4. Quality & Post-Market Systems

RA teams interact with QMS documentation throughout the product lifecycle for submissions and maintenance.

ISO 13485 and Post-Market Surveillance

  • QMS documentation requirements interfacing with regulatory submissions
  • Post-market surveillance per EU MDR Articles 83-86
  • Vigilance reporting per Articles 87-92 with timeline requirements
  • Field safety corrective actions and recall documentation
Impact on documentation
  • Post-market surveillance reports feed into regulatory submissions and must be kept current
  • Vigilance reporting timelines are strict — serious incidents require reporting within 15 days

5. Documentation Standards & Traceability

RA teams must ensure all documentation meets applicable standards for structure, labeling, and traceability.

Labeling and Instructions

  • IEC/IEEE 82079-1 for user instruction documentation
  • EU MDR Annex I Chapter III labeling requirements
  • Electronic instructions for use (eIFU) per EU 2021/2226
  • Translation and localization requirements per market
Impact on documentation
  • Labeling non-compliance is a high-frequency Notified Body finding that can delay certification
  • eIFU regulations have specific conditions that must be met to replace paper IFU

What happens when documentation falls short

  • CE marking delays from incomplete technical documentation
  • FDA warning letters from QSR non-compliance
  • MDSAP audit findings affecting multiple market authorizations simultaneously
  • Product recalls from inconsistent documentation across markets
  • Missed compliance deadlines from regulatory intelligence gaps

What this means for your team

EU MDR technical documentation aligned to Annex II/III requirements
FDA submission pathways mapped and documented for each product
International regulatory strategy documented per target market
QMS documentation meets ISO 13485 audit expectations
Post-market surveillance system generates required regulatory reports on schedule
Document version control maintains audit trail across all submissions

How Vespper serves regulatory affairs teams

Native source traceability

Every claim in your regulatory document links to the test report, clinical study, or design document that supports it — no separate traceability matrix needed.

Authority-specific templates

Draft documents following FDA, EU MDR, Health Canada, or other authority-specific structures with proper section organization.

Auditable revision history

Every edit is tracked with full before/after visibility, who made the change, and when — meeting regulated environment requirements.

Cross-document consistency

Maintain consistent terminology, product descriptions, and claims across your entire regulatory document portfolio.

How regulatory teams use Vespper

1

Connect your regulatory data

Upload test reports, clinical data, design documentation, predicate comparisons, and regulatory guidance documents.

2

Draft regulatory documents with AI

Generate submissions, CERs, technical files, or risk assessments with every claim traced to your source evidence.

3

Review, revise, and submit

Review AI suggestions in diff view, maintain auditable revision records, and export in authority-required formats.

Built for

Regulatory Affairs DirectorsRegulatory SpecialistsRegulatory ConsultantsQuality Regulatory Managers

Related solutions

The document editor regulatory affairs teams deserve

Draft regulatory documents with built-in traceability, structured output, and auditable revisions.

Sign in
Vespper Logo
The AI editor for professional documents